文献速递脊柱关节炎

银屑病关节炎合并代谢综合征患者呈现难治性表型:一个仍未定义的患者亚群中的又一块马赛克拼图

Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients.
PubMed 文献 · RMD Open · 2025-06-22

本研究为横断面研究,纳入182例银屑病关节炎(PsA)患者,42.94%符合代谢综合征(MetS)标准。难治性(D2T)亚组(n=66)的MetS患病率显著高于非D2T组(81.82% vs 29.37%,p<0.0001),MetS与D2T PsA强相关(OR 7.56,95%CI 2.53至22.56,p<0.0001),路径分析证实MetS为D2T表型的独立预测因素。

要点

  • 182例PsA患者中42.94%符合MetS标准,D2T亚组(n=66)MetS患病率81.82%,显著高于非D2T组的29.37%(p<0.0001)。
  • MetS与D2T PsA强相关(OR 7.56,95%CI 2.53至22.56,p<0.0001),路径分析证实MetS为D2T表型的独立预测因素。
  • 作者认为代谢合并症参与疾病严重度和治疗抵抗,处理代谢功能障碍可能对优化PsA治疗结局至关重要。

核心结论

  • MetS与PsA的D2T表型强相关,提示代谢合并症参与疾病严重度和治疗抵抗。
  • 作者认为处理代谢功能障碍可能对优化PsA管理中的治疗结局至关重要。

研究设计与样本

  • 横断面研究,纳入罗马Fondazione Policlinico Campus Bio-Medico风湿科门诊招募的182例符合银屑病关节炎分类标准的PsA患者。
  • 按国家胆固醇教育计划成人治疗组III标准评估MetS,按Perrotta等修订的类风湿关节炎欧洲风湿病学联盟协会标准定义D2T PsA。
  • 采用逻辑回归和路径分析探讨MetS与D2T PsA的关联。

主要发现

  • 182例PsA患者中42.94%符合MetS标准。
  • D2T亚组(n=66)MetS患病率为81.82%,非D2T组为29.37%(p<0.0001)。
  • 逻辑回归显示MetS与D2T PsA强相关(OR 7.56,95%CI 2.53至22.56,p<0.0001)。
  • 路径分析证实MetS为D2T表型的独立预测因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Psoriatic arthritis (PsA) is a chronic inflammatory condition associated with psoriasis and characterised by heterogeneous clinical manifestations, including peripheral and axial arthritis, enthesitis and dactylitis. A subset of patients exhibits a 'difficult-to-treat' (D2T) phenotype, necessitating complex therapeutic strategies. Metabolic syndrome (MetS) is highly prevalent in PsA patients and has been implicated in increased disease activity.This study aimed to evaluate the impact of MetS on the development of D2T phenotype in PsA and its potential implications for disease management. METHODS: A cross-sectional study was conducted on PsA patients recruited from the Rheumatology Clinic at Fondazione Policlinico Campus Bio-Medico of Rome. Patients fulfilling the Classification Criteria for Psoriatic Arthritis criteria were assessed for disease activity and the presence of MetS according to National Cholesterol Education Programme Adult Treatment Panel III criteria. D2T PsA was defined based on the Rheumatoid Arthritis European Alliance of Associations for Rheumatolog criteria revised for PsA by Perrotta et al. Statistical analyses, including logistic regression and path analysis, were performed to explore associations between MetS and D2T PsA. RESULTS: Among 182 PsA patients, 42.94% met MetS criteria. The D2T subset (n=66) demonstrated a significantly higher prevalence of MetS (81.82% vs 29.37%, p<0.0001). Logistic regression revealed a strong association between MetS and D2T PsA (OR 7.56, 95% CI 2.53 to 22.56, p<0.0001), and path analysis confirmed MetS as an independent predictor of D2T phenotype. CONCLUSIONS: MetS is strongly associated with a D2T phenotype in PsA, suggesting that metabolic comorbidities contribute to disease severity and treatment resistance. Addressing metabolic dysfunction may be crucial in optimising therapeutic outcomes in PsA management.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Currado D, Trunfio F, Saracino F, et al. Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients. RMD Open. 2025. PMID: 40545272. doi:10.1136/rmdopen-2025-005717

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。